Novo Nordisk, Hims & Hers Reportedly End Obesity Drug Feud, Aim To Partner

Novo Nordisk, Hims & Hers Reportedly End Obesity Drug Feud, Aim To Partner The potential partnership comes a month after Novo sued Hims over obesity drug knockoffs. Also: A new study finds that generic versions of Ozempic and Wegovy could be sold for less than $3 a month. https://kffhealthnews.org/morning-breakout/novo-nordisk-hims-hers-reportedly-end-obesity-drug-feud-aim-to-partner/